Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment

Although immune checkpoint inhibitors (ICIs) are increasingly used as second-line treatments for urothelial cancer (UC), only a small proportion of patients respond. Therefore, understanding the mechanisms of response to ICIs is critical to improve clinical outcomes for UC patients. The tumor microe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sternberg, Cora N., Shin, Nara, Chernyshov, Konstantin, Calabro, Fabio, Cerbone, Linda, Procopio, Giuseppe, Miheecheva, Natalia, Sagaradze, Georgy, Zaichikova, Alisa, Samarina, Naira, Boyko, Alexandra, Brown, Jessica H., Yunusova, Leysan, Guevara, Daniela, Manohar, Jyothi, Sigouros, Michael, Al Assaad, Majd, Elemento, Olivier, Mosquera, Juan Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661726/
https://www.ncbi.nlm.nih.gov/pubmed/36387205
http://dx.doi.org/10.3389/fonc.2022.1006017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661726/
https://www.ncbi.nlm.nih.gov/pubmed/36387205
http://dx.doi.org/10.3389/fonc.2022.1006017

Ejemplares similares